Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Cheng, Yuan Lung ^a   Wang, Yuan Jen ^a,b   Kao, Wei Yu ^b,c   Chen, Ping Hsien ^a,b   Huo, Teh Ia ^a,b   Huang, Yi Hsiang ^a,b   Lan, Keng Hsin ^a,b   Su, Chien Wei ^a,b   Chan, Wan Leong ^a,b   Lin, Han Chieh ^a,b   Lee, Fa Yauh ^a,b   Wu, Jaw Ching ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HELP SEEKING BEHAVIOR; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TAIWAN; THROMBOCYTE COUNT; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COMORBIDITY; FATTY LIVER; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PLATELET COUNT; PREVALENCE; TAIWAN; WAIST CIRCUMFERENCE;

EID: 84882753071     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072049     Document Type: Article

References (44)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142: 1592-1609.
2. Wu WC, Wu CY, Wang YJ, Hung HH, Yang HI, et al. (2012) Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment Pharmacol Ther 36: 560-568.
3. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9: 524-530.
4. Vernon G, Baranova A, Younossi ZM, (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34: 274-285.
5. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, et al. (2007) Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 47: 239-244.
6. Hou XH, Zhu YX, Lu HJ, Chen HF, Li Q, et al. (2011) Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J Gastroenterol Hepatol 26: 722-730.
7. Wong VW, Wong GL, Chu WC, Chim AM, Ong A, et al. (2012) Hepatitis B virus infection and fatty liver in the general population. J Hepatol 56: 533-540.
8. Hsu CS, Liu CH, Wang CC, Tseng TC, Liu CJ, et al. (2012) Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat 19: e48-57.
9. Machado MV, Oliveira AG, Cortez-Pinto H, (2011) Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 26: 1361-1367.
10. Lee IC, Huang YH, Chan CC, Huo TI, Chu CJ, et al. (2011) Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B. Clin Nutr. 30: 647-652.
11. Yun JW, Cho YK, Park JH, Kim HJ, Park DI, et al. (2009) Hepatic steatosis and fibrosis in young men with treatment-naive chronic hepatitis B. Liver Int. 29: 878-883.
12. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS, (2008) Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 23: 779-782.
13. Zhang Z, Pan Q, Duan XY, Liu Q, Mo GY, et al. (2012) Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model. J Gastroenterol Hepatol 27: 1858-1864.
14. Na TY, Shin YK, Roh KJ, Kang SA, Hong I, et al. (2009) Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology 49: 1122-1131.
15. Jan CF, Chen CJ, Chiu YH, Chen LS, Wu HM, et al. (2006) A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond) 30: 794-799.
16. Peng D, Han Y, Ding H, Wei L, (2008) Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol 23: 1082-1088.
17. Shi JP, Fan JG, Wu R, Gao XQ, Zhang L, et al. (2008) Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 23: 1419-1425.
18. Chiang CH, Yang HI, Jen CL, Lu SN, Wang LY, et al. (2013) Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes 37: 410-415.
19. Huang KW, Leu HB, Wang YJ, Luo JC, Lin HC, et al. (2013) Patients with non-alcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy. Colorectal Dis (in press).
20. Liu CJ, (2012) Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 27: 1555-1560.
21. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 6: 33.
22. Farrell GC, Larter CZ, (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112.
23. Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, et al. (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 57: 1305-1311.
24. Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, et al. (2013) External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study. Clin Gastroenterol Hepatol (in press).
25. Nascimento AC, Maia DR, Neto SM, Lima EM, Twycross M, et al. (2012) Nonalcoholic Fatty liver disease in chronic hepatitis B and C patients from Western Amazon. Int J Hepatol 2012: 695950.
26. Fan JG, Farrell GC, (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50: 204-210.
27. Yuen MF, Wong DK, Fung J, Ip P, But D, et al. (2008) HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 135: 1192-1199.
28. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, et al. (2010) Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 139: 474-482.
29. Tai DI, Tsay PK, Chen WT, Chu CM, Liaw YF, (2010) Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age. Am J Gastroenterol 105: 1102-1109.
30. Chu CM, Lin DY, Liaw YF, (2007) Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? Int J Obes (Lond) 31: 871-875.
31. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, et al. (2009) Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 58: 111-117.
32. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, et al. (2008) Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 26: 5576-5582.
33. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, et al. (2007) Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 22: 1482-1489.
34. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, et al. (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36: 451-455.
35. Kao WY, Su CW, Huang YS, Chou YC, Chen YC, et al. (2013) Risk of Oral Anti-fungal Agent-Induced Liver Injury in Taiwanese. Brit J Clin Pharmacol (in press).
36. Hershko C, (2009) Iron overload in Asia. Blood 114: 1-2.
37. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, et al. (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51: 2193-2213.
38. Su CW, Chan CC, Hung HH, Huo TI, Huang YH, et al. (2009) Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis. J Clin Gastroenterol 43: 876-883.
39. Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, et al. (2010) Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19: 1261-1268.
40. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD, (1991) Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43: 26-31.
41. Haring R, Wallaschofski H, Nauck M, Dorr M, Baumeister SE, et al. (2009) Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 50: 1403-1411.
42. Su CW, Wu CY, Hung HH, Wu CH, Sheen IJ, et al. (2013) Differential roles of serum HBV DNA and HBsAg level in predicting virological breakthrough in patients receiving lamivudine therapy. J Gastroenterol Hepatol (in press).
43. Su CW, Chiou YW, Tsai YH, Teng RD, Chau GY, et al. (2013) The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy. PLoS ONE 8: e66457.
44. Jin X, Chen YP, Yang YD, Li YM, Zheng L, et al. (2012) Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. PLoS ONE. 7: e34198.